Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | CTMX | MNKD | ||
| Company | Lexicon Pharmaceutcl | Cytomx Thera | Mannkind Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.6600 | 4.15 | 2.25 | ||
| High | 1.7000 | 4.19 | 2.31 | ||
| Low | 1.6501 | 4.11 | 2.24 | ||
| Latest | 1.6650 | 4.21 | 2.31 | ||
| Change | -0.0150 | -0.01 | +0.03 | ||
| % Change | -0.89% | -0.24% | +1.32% | ||
| Volume | 204,250 | 145,811 | 961,622 | ||
| 20-Day Average Volume | 2,670,633 | 12,620,713 | 7,065,128 | ||
| Previous Close | 1.6800 | 4.22 | 2.28 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.6393 | 4.86 | 2.69 | ||
| 20-Day Raw Stochastic | 71.62% | 1.21% | 4.42% | ||
| 20-Day Relative Strength | 57.35 | 43.14 | 22.06 | ||
| Weighted Alpha | +206.27 | +147.33 | -48.46 | ||
| Today's Opinion | 100% Buy | 24% Buy | 88% Sell | ||
| Previous Opinion | 100% Buy | 24% Buy | 88% Sell | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.01% since 03/19/26 | -13.60% since 03/19/26 | -9.13% since 03/19/26 | ||
| Low | 1.5150 on 03/20/26 | 4.08 on 03/25/26 | 2.24 on 03/26/26 | ||
| High | 1.7700 on 03/25/26 | 4.77 on 03/20/26 | 2.59 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | +12.33% since 02/26/26 | -24.64% since 02/26/26 | -29.32% since 02/26/26 | ||
| Low | 1.4200 on 03/02/26 | 4.08 on 03/25/26 | 2.24 on 03/26/26 | ||
| High | 1.7900 on 03/13/26 | 8.21 on 03/16/26 | 3.37 on 02/27/26 | ||
| 3-Month | |||||
| %Chg | +36.99% since 12/26/25 | -5.92% since 12/26/25 | -60.45% since 12/26/25 | ||
| Low | 1.1000 on 01/30/26 | 3.98 on 01/05/26 | 2.24 on 03/26/26 | ||
| High | 1.8300 on 01/22/26 | 8.21 on 03/16/26 | 6.51 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +20.36% since 09/26/25 | +42.41% since 09/26/25 | -58.59% since 09/26/25 | ||
| Low | 1.1000 on 01/30/26 | 2.93 on 09/29/25 | 2.24 on 03/26/26 | ||
| High | 1.8300 on 01/22/26 | 8.21 on 03/16/26 | 6.51 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 711,784 | 718,189 | 702,468 | ||
| Shares Outstanding, K | 423,681 | 170,187 | 308,100 | ||
| Annual Sales | 49,800,000 | 76,200,000 | 348,970,000 | ||
| Annual Net Income | -50,340,000 | -17,370,000 | 5,860,000 | ||
| Last Quarter Sales | 5,490,000 | 660,000 | 111,960,000 | ||
| Last Quarter Net Income | -15,530,000 | -26,510,000 | -15,950,000 | ||
| 60-Month Beta | 0.94 | 2.44 | 0.83 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 03/05/26 | -0.22 on 03/16/26 | -0.05 on 02/26/26 | ||
| Latest Earnings Date | 05/12/26 | 05/11/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 114.50 | ||